Irritable Bowel Syndrome Trial, Recruiting (NCT06489444)

Irritable Bowel Syndrome Trial, Recruiting NCT06489444 Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06489444 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS) based on specific medical guidelines (called Rome IV criteria), meaning you have recurring stomach pain at least 1 day per week on average over the last 3 months, along with 2 or more of the following: pain related to going to the toilet, changes in how often you have bowel movements, or changes in what your stools look like — and these symptoms first started at least 6 months ago
You are 18 years old or older

Who may not be able to join:

You have a history of coeliac disease or other diagnosed bowel diseases, or certain metabolic conditions such as thyroid problems or diabetes
You have a serious neurological, mental health, or psychological condition, or serious problems with how a major organ in your body functions
You have previously had abdominal (stomach area) surgery
You are pregnant, think you might be pregnant, or are currently breastfeeding
You have had a colonoscopy (a camera examination of the bowel) within the past year
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13609281113

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06489444

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: 13609281113

More information: https://clinicaltrials.gov/study/NCT06489444

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS) based on specific medical guidelines (called Rome IV criteria), meaning you have recurring stomach pain at least 1 day per week on average over the last 3 months, along with 2 or more of the following: pain related to going to the toilet, changes in how often you have bowel movements, or changes in what your stools look like — and these symptoms first started at least 6 months ago
You are 18 years old or older

Who may not be able to join:

You have a history of coeliac disease or other diagnosed bowel diseases, or certain metabolic conditions such as thyroid problems or diabetes
You have a serious neurological, mental health, or psychological condition, or serious problems with how a major organ in your body functions
You have previously had abdominal (stomach area) surgery
You are pregnant, think you might be pregnant, or are currently breastfeeding
You have had a colonoscopy (a camera examination of the bowel) within the past year
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Registry

ClinicalTrials.gov

Start date

16 March 2023

Est. completion

1 August 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Taste receptor expression was associated with symptom severity; Association between fecal amino acid levels and symptom severity in patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov